Skip to main content

#158349

JU77R cell line

Cat. #158349

JU77R cell line

Cat. #: 158349

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Lung

Disease: Cancer

Model: Cancer Model

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Sarah A Martin

Institute: Queen Mary University of London

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: JU77R cell line
  • Cancer: Lung cancer
  • Cancers detailed: Lung
  • Research fields: Cancer
  • Tool sub type: Continuous
  • Parental cell: JU77
  • Organism: Human
  • Tissue: Lung
  • Disease: Cancer
  • Growth properties: Human mesothelioma cell line resistant to pegylated arginine deiminase (ADI-PEG20).
  • Model: Cancer Model
  • Production details: JU77 cells were incubated with 10ug/ml ADI-PEG20 in RPMI-1640 media supplemented with 2% FBS and re-treated every week. After approximately 2 months, colonies were picked and seeded in a 96-well plate with 10ug/ml ADI-PEG20. A surviving clone (JU777R) was gradually expanded and maintained in 1ug/ml ADI-PEG20.
  • Cellosaurus id: TBC

Target Details

  • Target: Human mesothelioma cell line resistant to pegylated arginine deiminase (ADI-PEG20)

Handling

  • Format: Frozen
  • Growth medium: RPMI-1640 media (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Invitrogen), 100 U/ml penicillin, and 100ug/ml streptomycin at 37?‚°C/5% CO2.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

References

  • Locke et al. 2016. Cell Rep. 16(6):1604-1613. PMID: 27452468.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.